10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001564590-22-017878`
Period End Date	20220331
Filing Date	20220504
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	rgnx-10q_20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 38 Cash Flow Statement 67 Stockholders Equity 20

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$291.48M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$191.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$345.21M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$202.26M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$112.23M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$32.44M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$27.02M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$18.54M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$18.75M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.83M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.18M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$10.20M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.98M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$518.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$446.88M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.83M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.98M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$391.91M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$370.66M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$2.26M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$2.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$131.55M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$135.26M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$60.90M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$59.92M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$8.53M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.43M	USD	Point-in-time
Total assets	`Assets`	$1.11B	USD	Point-in-time
Total assets	`Assets`	$1.03B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$24.71M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.39M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$48.42M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$76.11M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$3.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$3.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.12M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$37.89M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$41.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$130.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$119.94M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$85.57M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$84.93M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$133.46M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$122.51M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$7.68M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$745.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$349.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$335.70M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2022 and December 31, 2021; 42,982 and 42,831 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2022 and December 31, 2021; 42,982 and 42,831 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$928.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$939.57M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.57M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-11.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-161.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-237.96M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$689.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$764.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$554.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.75M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.03B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.11B	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$22.22M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$18.88M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$4.85M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$15.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$39.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$55.63M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$22.32M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$17.84M	USD	1 Quarter
Credit losses and other	`CreditLossesAndOther`	$83.00K	USD	1 Quarter
Credit losses and other	`CreditLossesAndOther`	$515.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$62.93M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$93.75M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-71.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-44.04M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$94.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$29.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$580.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$799.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$6.13M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.70M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-5.24M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.09M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-76.76M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-50.13M	USD	1 Quarter
Income Tax Benefit (Expense)	`IncomeTaxExpenseBenefit`	$-41.00K	USD	1 Quarter
Income Tax Benefit (Expense)	`IncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-76.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-50.14M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-9.38M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.01M	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.01M	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-9.38M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-51.15M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-86.10M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.79	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	41,819.00	shares	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	42,944.00	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-76.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-50.14M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.92M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$10.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.59M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.93M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$565.00K	USD	1 Quarter
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.46M	USD	1 Quarter
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.29M	USD	1 Quarter
Net gains on investments	`GainLossOnInvestments`	$7.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$94.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$29.00K	USD	1 Quarter
Non-cash interest expense	`NonCashInterestExpense`	$54.00K	USD	1 Quarter
Non-cash interest expense	`NonCashInterestExpense`	$3.79M	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$154.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$43.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.69M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.62M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.33M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-210.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-3.04M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$873.00K	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.23M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-979.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.10M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$3.79M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$16.75M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$278.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-10.54M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-26.47M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$1.01M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$4.24M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.93M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-38.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-44.05M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.91M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$233.63M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$129.49M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.47M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$49.86M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.02M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.97M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-90.59M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-214.18M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.29M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$337.00K	USD	1 Quarter
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$284.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$627.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$622.00K	USD	1 Quarter
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuancesOfCommonStockNetOfUnderwritingDiscountsAndCommissions`	$216.44M	USD	1 Quarter
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$251.00K	USD	1 Quarter
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$6.55M	USD	1 Quarter
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$7.51M	USD	1 Quarter
Transaction costs for sale of future royalties	`PaymentsOfTransactionCostsForSaleOfFutureLoyalties`	$265.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$211.29M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.83M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-153.34M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-46.94M	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$193.90M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$292.81M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$193.90M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$292.81M	USD	Point-in-time

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time
Issuance of common stock upon public offering, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$216.06M	USD	1 Quarter
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-284.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$337.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$627.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$622.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.92M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.80M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-9.38M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-76.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-50.14M	USD	1 Quarter
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.